Author

Matthieu Galtier

Institution: Eligo Bioscience (France)

Observed institutions: Institut Pasteur, Sorbonne Paris Cité, Eligo Bioscience (France), Université Paris Diderot

OpenAlex ID: A5053153998

Bacteriophages targeting adherent invasive Escherichia coli strains as a promising new treatment for Crohn's disease

2017 · Matthieu Galtier, Luisa De Sordi, et al. · Journal of Crohn s and Colitis · 220

Bacteriophages to reduce gut carriage of antibiotic resistant uropathogens with low impact on microbiota composition

2016 · Matthieu Galtier, Luisa De Sordi, et al. · Environmental Microbiology · 157

In situ targeted base editing of bacteria in the mouse gut

2024 · Andreas K. Brödel, Loïc H. Charpenay, et al. · Nature · 144

Virulent Bacteriophages Can Target O104:H4 Enteroaggregative Escherichia coli in the Mouse Intestine

2012 · Damien Maura, Matthieu Galtier, et al. · Antimicrobial Agents and Chemotherapy · 104

Treatment of Shiga toxin–producing E. coli infection by CRISPR-Cas–targeted cleavage of the Shiga toxin gene in animal models

2026 · Matthieu Galtier, Antonina Krawczyk, et al. · Science Translational Medicine · 10

Co-évolution bactériophages-bactéries dans l’intestin murin : application à la phagothérapie ciblant des Escherichia coli

2014 · Matthieu Galtier

Works count: 6

Citation count: 635

H-index: 5

I10-index: 5